Trulieve Cannabis Corp (TCNNF)
6.80
+0.23
(+3.50%)
USD |
OTCM |
Nov 15, 16:00
Trulieve Cannabis Revenue (Quarterly): 284.28M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 284.28M |
June 30, 2024 | 303.44M |
March 31, 2024 | 297.62M |
December 31, 2023 | 286.97M |
September 30, 2023 | 275.21M |
June 30, 2023 | 281.80M |
March 31, 2023 | 285.21M |
December 31, 2022 | 298.48M |
September 30, 2022 | 295.35M |
June 30, 2022 | 313.84M |
March 31, 2022 | 317.75M |
December 31, 2021 | 298.90M |
September 30, 2021 | 224.09M |
Date | Value |
---|---|
June 30, 2021 | 215.12M |
March 31, 2021 | 193.82M |
December 31, 2020 | 168.44M |
September 30, 2020 | 136.27M |
June 30, 2020 | 120.76M |
March 31, 2020 | 96.06M |
December 31, 2019 | 79.69M |
September 30, 2019 | 70.73M |
June 30, 2019 | 57.92M |
March 31, 2019 | 44.48M |
December 31, 2018 | 35.95M |
September 30, 2018 | 28.33M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
79.69M
Minimum
Dec 2019
317.75M
Maximum
Mar 2022
238.66M
Average
283.04M
Median
Revenue (Quarterly) Benchmarks
Bruker Corp | 864.40M |
Karyopharm Therapeutics Inc | 38.78M |
Apellis Pharmaceuticals Inc | 196.83M |
cbdMD Inc | 5.174M |
Flora Growth Corp | 15.68M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -60.21M |
Total Expenses (Quarterly) | 287.96M |
EPS Diluted (Quarterly) | -0.33 |
Enterprise Value | 1.446B |
Gross Profit Margin (Quarterly) | 60.95% |
Profit Margin (Quarterly) | -21.18% |
Earnings Yield | -10.74% |
Operating Earnings Yield | 9.49% |
Normalized Earnings Yield | -10.50 |